|
| 36672910 | Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy. | | 2023 |
| 36443464 | Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan. | European Journal of Human Genetics | 2023 |
| 37693320 | Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients. | | 2023 |
| 36509836 | Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. | | 2023 |
| 37002327 | Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. | | 2023 |
| 36797469 | Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan. | | 2023 |
| 37236847 | Factors influencing pharmacists' clinical decision making in pharmacy practice. | | 2023 |
| 34490590 | Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial. | American Journal of Cardiovascular Drugs | 2022 |
| 35988587 | CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD). | American Heart Journal | 2022 |
| 36123233 | Clinical reasoning by pharmacists: A scoping review. | | 2022 |
| 36056234 | Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. | European Journal of Human Genetics | 2022 |
| 35723240 | Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome. | European Heart Journal - Cardiovascular Pharmacotherapy | 2022 |
| 34233065 | Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial. | Catheterization and Cardiovascular Interventions | 2022 |
| 34267337 | Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). | European Journal of Human Genetics | 2022 |
| 35301821 | The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. | Journal of Cachexia, Sarcopenia and Muscle | 2022 |
| 34565798 | Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). | European Journal of Human Genetics | 2022 |
| 34782755 | Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. | European Journal of Human Genetics | 2022 |
| 34834585 | Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. | J Pers Med | 2021 |
| 33722066 | Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. | Circulation: Cardiovascular Interventions | 2021 |
| 33053622 | Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial. | Journal of Clinical Medicine | 2020 |
| 31745289 | Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines. | European Journal of Human Genetics | 2020 |
| 32139231 | Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7Â Days After STEMI. | JACC: Cardiovascular Interventions | 2020 |
| 32317559 | Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study. | Pharmacogenet Genomics | 2020 |
| 31884246 | A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial. | American Heart Journal | 2020 |
| 32334703 | Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. | Lancet, The | 2020 |
| 32383328 | Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. | Thoracic Cancer | 2020 |
| 32205584 | Pharmacogenetics of antitumor necrosis factor therapy in severe sarcoidosis. | Current Opinion in Pulmonary Medicine | 2020 |
| 33568995 | Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines. | Frontiers in Pharmacology | 2020 |
| 32932966 | Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. | Genes (Basel) | 2020 |
| 32862716 | Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial. | Circulation | 2020 |
| 33073546 | Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: Design of the multicenter PGxLUNG study. | Thoracic Cancer | 2020 |
| 31479209 | A Genotype-Guided Strategy for Oral P2Y Inhibitors in Primary PCI. | New England Journal of Medicine | 2019 |
| 31197411 | Tailored P2Y inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study. | European Journal of Clinical Pharmacology | 2019 |
| 31312209 | Use of Pharmacogenetic Drugs by the Dutch Population. | Frontiers in Genetics | 2019 |
| 29496351 | Efficacy and safety of infliximab biosimilar Inflectra in severe sarcoidosis. | Respiratory Medicine | 2018 |
| 29748932 | Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial. | Paediatric Drugs | 2018 |
| 29701129 | Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy. | Pharmacogenomics | 2018 |
| 29460273 | Pharmacogenetic Information in Clinical Guidelines: The European Perspective. | Clinical Pharmacology and Therapeutics | 2018 |
| 28027596 | Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. | Clin Pharmacol Ther | 2017 |
| 28697492 | Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience. | Cardiology | 2017 |
| 30239993 | CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. | Clin Pharmacol Ther | 2017 |
| 27662521 | Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period. | British Journal of Clinical Pharmacology | 2017 |
| 27537726 | Repositioning 'old' drugs to treat rare diseases: arguing from the mechanism of action. | | 2016 |
| 26920599 | Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation. | American Heart Journal | 2016 |
| 27215507 | Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. | Respiratory Medicine | 2016 |
| 26542508 | Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE study. | American Heart Journal | 2015 |
| 25929955 | Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. | European Respiratory Journal | 2015 |
| 25804106 | [A potentially fatal intoxication with colchicine]. | Nederlands Tijdschrift voor Geneeskunde | 2015 |
| 26098292 | Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis? | Immunotherapy | 2015 |
| 24581153 | Application of routine electronic health record databases for pharmacogenetic research. | Journal of Internal Medicine | 2014 |